Global Blood Therapeutics
$40.779876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$40.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.45 (-1.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell GBT and other stocks, options, and ETFs commission-free!
About GBT
Global Blood Therapeutics, Inc. Common Stock, also called Global Blood Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders.
CEO
Ted W. Love
Employees
389
Headquarters
South San Francisco, California
Founded
2011
Market Cap
2.61B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
827.35K
High Today
$41.57
Low Today
$40.22
Open Price
$41.01
Volume
976.47K
52 Week High
$83.69
52 Week Low
$36.49
Analyst Ratings
71%
of 21 ratings
Buy
71%
Hold
29%
Sell
0%
GBT Earnings
-$1.59
-$1.06
-$0.53
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours